SkyView Investment Advisors’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-378
Closed -$174K 788
2023
Q1
$174K Buy
378
+61
+19% +$29K 0.04% 354
2022
Q4
$162K Buy
+317
New +$161K 0.05% 349
2022
Q2
Sell
-552
Closed -$271K 592
2022
Q1
$271K Sell
552
-31,896
-98% -$14.6M 0.06% 369
2021
Q4
$228K Buy
+32,448
New +$13.7M 0.05% 386

Other funds holding ELV

SkyView Investment Advisors's ELV Position: Q2 2023 in Review

SkyView Investment Advisors sold out of Elevance Health (ELV) in Q2 2023, closing a stake of 378 shares — an estimated $174K sold.

SkyView Investment Advisors first reported a position in ELV in Q4 2021 and held it in 4 quarters. The position peaked at $271K in Q1 2022. 1,523 funds tracked by Wall St. Rank hold ELV as of Q2 2023.

  • SkyView Investment Advisors reported no remaining Elevance Health position as of Q2 2023 after selling out during the quarter.
  • SkyView Investment Advisors sold 378 Elevance Health shares in Q2 2023, an estimated $174K.
  • SkyView Investment Advisors first reported a position in Elevance Health in Q4 2021 and held it in 4 quarters.
  • SkyView Investment Advisors's Elevance Health position peaked at $271K in Q1 2022.
  • 1,523 funds tracked by Wall St. Rank held Elevance Health as of Q2 2023.

Based on SkyView Investment Advisors's 13F filing for Q2 2023, filed 15 Aug 2023.